CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 10th, 2020 • Principia Biopharma Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 10th, 2020 Company Industry JurisdictionThis Change in Control and Agreement (the “Agreement”) is dated as of April 18, 2019, by and between Dolca Thomas, M.D. ("Executive") and Principia Biopharma, Inc., a Delaware corporation, including its subsidiaries (the "Company"), effective as of October 22, 2018 (the “Effective Date”). This Agreement is intended to provide Executive with certain benefits described herein upon the occurrence of specific events.
PRINCIPIA BIOPHARMA, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • September 4th, 2018 • Principia Biopharma Inc. • Pharmaceutical preparations • California
Contract Type FiledSeptember 4th, 2018 Company Industry JurisdictionThis Change in Control and Severance Agreement (the “Agreement”) is dated as of , 2018, by and between [ ] (“Executive”) and Principia Biopharma Inc., a Delaware corporation, including its subsidiaries (the “Company”), effective as of , 2018 (the “Effective Date”). This Agreement is intended to provide Executive with certain benefits described herein upon the occurrence of specific events.